News

The study demonstrated that the Tecentriq combination has more effectively reduced the disease progression in patients compared to those who received Avastin plus chemotherapy. IMpower150 is a multicenter,

Cryotherapy is the general utilization of low temperatures in therapeutic treatment. It is utilized to cure a range of favorable and threatening tissue break, medically called as sores.

The companies will work together to advance TC BioPharm’s lead CAR-engineered gamma delta T cell program into clinical trials as well as on additional hematologic and solid tumor

Based in Emeryville, California, Cell Design Labs is a pre-clinical stage company, focused on developing disruptive CAR-T and T cell receptor (TCR) therapies to advance discovery and development

The investment will support GSK’s research to generate genetic sequencing data from UK Biobank. GSK will sequence the data from all 500,000 volunteer participants following the first 50,000

The two-year collaboration is being led by Dan S. Kaufman, M.D., Ph.D., Professor of Medicine in the Division of Regenerative Medicine and Director of Cell Therapy at UC

As part of the agreement, Carmot will apply its proprietary lead-identification technology, Chemotype Evolution, to discover and advance novel drug leads intended for the treatment of Parkinson’s disease

The trial, dubbed MONALEESA-7, saw Kisqali, a CDK4/6 inhibitor, combined with an aromatase inhibitor or tamoxifen and goserelin as initial endocrine-based therapy pitted against endocrine therapy and goserelin alone.

Janssen Biotech, along with AbbVie’s Pharmacyclics, has developed Imbruvica, which is a first-in-class Bruton's tyrosine kinase inhibitor. iNNOVATE is a Pharmacyclics-sponsored, randomized, placebo-controlled and double-blind study designed to